Publicación:
A tiered next-generation risk assessment framework integrating toxicokinetics and NAM-based toxicodynamics: “proof of concept” case study using pyrethroids

dc.contributor.authorFernandez Agudo, Ana
dc.contributor.authorTarazona, Jose
dc.date.accessioned2025-05-20T10:59:37Z
dc.date.available2025-05-20T10:59:37Z
dc.date.issued2025-05-07
dc.descriptionThe registered version of this article, first published in “Archives of Toxicology (2025)", is available online at the publisher's website: Springer, https://doi.org/10.1007/s00204-025-04045-9 La versión registrada de este artículo, publicado por primera vez en “Archives of Toxicology (2025)", está disponible en línea en el sitio web del editor: Springer, https://doi.org/10.1007/s00204-025-04045-9
dc.description.abstractNew Approach Methodologies (NAMs) in Next-Generation Risk Assessment (NGRA), integrating toxicokinetics (TK) with toxicodynamics (TD), provides an accurate evaluation of combined chemical exposures. This study assesses pyrethroids, which pose regulatory challenges due to their widespread use and cumulative exposure risks. A tiered NGRA framework was compared with conventional risk assessment (RA) to evaluate regulatory applicability. In Tier 1, ToxCast data established gene and tissue bioactivity indicators, facilitating hypothesis-driven hazard identification. Tier 2 examined combined risk assessments, rejecting the hypothesis of the same mode of action and highlighting inconsistencies in in vitro data and NOAEL/ADI correlations. Tier 3 applied Margin of Exposure (MoE) analysis and TK modeling to realistic exposure estimations for risk assessment screening based on internal doses, identifying tissue-specific pathways as critical risk drivers. Tier 4 refined bioactivity indicators using TK approaches to improve the NAM-based effect assessment, including an in vitro vs. in vivo comparison, with coherent results based on interstitial concentrations, though intracellular estimations remained uncertain. Tier 5 confirmed that dietary exposure in healthy adults is close to but below levels of concern, with bioactivity MoE values remaining below concern thresholds, and in vivo MoEs within the standard safety factors. Nevertheless, the MoEs are insufficient for addressing the additional non-dietary exposure expected from other pyrethroid uses such as biocides or pharmaceuticals. Results demonstrate that NGRA with TK-NAM-based TD offers a nuanced, regulatory-relevant framework for risk assessment. The proposed approach integrates the information on individual pyrethroids using bioactivity indicators; and the re-assessment of regulatory toxicity studies to select organ-relevant NOAELs allowed an improved in vitro-in vivo comparison, demonstrating the capacity of bioactivity-based MoEs for combined exposure assessments. This tiered approach provides key insights for regulatory decision-making, establishing a robust model for evaluating pyrethroids and similar chemical classes.en
dc.description.versionversión final
dc.identifier.citationFernandez-Agudo, A., Tarazona, J.V. A tiered next-generation risk assessment framework integrating toxicokinetics and NAM-based toxicodynamics: “proof of concept” case study using pyrethroids. Arch Toxicol (2025). https://doi.org/10.1007/s00204-025-04045-9
dc.identifier.doihttps://doi.org/10.1007/s00204-025-04045-9
dc.identifier.issn1432-0738 | 0340-5761
dc.identifier.urihttps://hdl.handle.net/20.500.14468/26565
dc.journal.titleArchives of Toxicology
dc.language.isoen
dc.publisherSpringer
dc.relation.centerFacultad de Ciencias
dc.relation.departmentCiencias y Técnicas Fisicoquímicas
dc.rightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/deed.es
dc.subject24 Ciencias de la Vida
dc.subject.keywordsNext-generation risk assessment (NGRA)en
dc.subject.keywordsNew Alternative Methods (NAMs)en
dc.subject.keywordstoxicokineticsen
dc.subject.keywordstoxicodynamicsen
dc.subject.keywordspyrethroidsen
dc.titleA tiered next-generation risk assessment framework integrating toxicokinetics and NAM-based toxicodynamics: “proof of concept” case study using pyrethroidsen
dc.typeartículoes
dc.typejournal articleen
dspace.entity.typePublication
Archivos
Bloque original
Mostrando 1 - 2 de 2
Cargando...
Miniatura
Nombre:
Fernandez-Agudo_Ana_ATieredNext-GenerationRis_ANA FERNANDEZ AGUDO.pdf
Tamaño:
1.61 MB
Formato:
Adobe Portable Document Format
Cargando...
Miniatura
Nombre:
Fernandez-Agudo_Ana_Suppl. Material_ATieredNe_ANA FERNANDEZ AGUDO.pdf
Tamaño:
1.02 MB
Formato:
Adobe Portable Document Format
Bloque de licencias
Mostrando 1 - 1 de 1
No hay miniatura disponible
Nombre:
license.txt
Tamaño:
3.62 KB
Formato:
Item-specific license agreed to upon submission
Descripción: